Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)50% (Hyper Growth)
EST. PRICE IN 2031
$80.67
Based on 3.7% avg growth
INTRINSIC VALUE TODAY
$50.09
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 11.5x Exit PE.
Valuation Analysis: MO is currently trading at $68.47, which is considered fair relative to its 30-day fair value range of $65.52 to $72.62. The stock's valuation (Forward PE: 11.3) is in line with its historical norms (11.5). Remarkably, the market is currently pricing in an annual earnings decline of 0.6% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, MO is showing sideways momentum. The price is approaching resistance at $68.73. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 3.6% recently.
Market Sentiment: MO scores 72/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$65.52 -
$72.62
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
83.3%
All Signals
NEUTRAL: Price in fair range
BULLISH: Strong technical setup (72/100)
BULLISH: High volume confirmation
BULLISH: Strong upward momentum (+3.6%)
NEUTRAL: Near Wall St target ($70.00)
BULLISH: Bottoming setup score 72/100 — corrected, stabilizing, and turning up
Trading Range Analysis
30-Day Trading Range
$65.52 -
$72.62
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level$63.92
Resistance Level$68.73
Current TrendSideways
Technical data as of
Aug 24, 2026
Fundamental Context
Forward P/E (Next Year Est.)11.27
Wall Street Target
$70.00
(+5.9%)
Revenue Growth (YoY)1.2%
Earnings Growth (YoY)-2.7%
Profit Margin39.0%
Valuation Discount vs History
-0.6% cheaper
PE vs Historical
11.3 vs 11.5
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):-0.6%
(market-implied from PE analysis)
1-Year Target
$65.69
(-1%)
2-Year Target
$65.30
(-1%)
3-Year Target
$64.91
(-2%)
3-Yr Target (if PE normalizes)
(PE: 11→12)
$66.23
(+0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.1, Growth: 3.3%)
$129.70
(+96%)
Base:
(SPY PE: 11.3, Growth: 3.3%)
$72.83
(+10%)
Bear:
(PE: 9.6, Growth: 3.3%)
$61.91
(-6%)
📈Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (14x PE), but valuation improves significantly next year (11x PE) as earnings recover.
Trailing PE: 13.92 | Current EPS (TTM): $4.81
Bull Case
$89.77
(+36%)
Analyst growth 21.9%, PE expands to 15.3
Base Case
$81.61
(+24%)
Market implied 21.9%, PE stable at 13.9
Bear Case
$45.52
(-31%)
Severe decline -20.0%, PE contracts to 11.8
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 11.3 to 11.5
Stabilization Target:
$67.44
(+2.0%)
PE Expansion Potential:
+2.0%
Share & Embed Analysis
Found this analysis useful? Share it with your community or embed the live chart on your blog.
Altria comprises Philip Morris USA, US Smokeless Tobacco, John Middleton, Horizon Innovations, and Helix Innovations. Through its tobacco subsidiaries, Altria maintains the leading position in cigarettes and smokeless tobacco in the United States and the number-two spot in machine-made cigars. The company's Marlboro brand is the leading cigarette brand in the US with 42% annual share in 2024. Beyond its core business, it holds an 8% interest in the world's largest brewer, Anheuser-Busch InBev and a 41% stake in cannabis manufacturer Cronos. It also acquired vaping company Njoy Holdings in 2023 and operates a joint venture with Japan Tobacco in the heated tobacco category for the US.